Nephria Bio attended the Young Startup Ventures Conference virtually this week, presenting on our flagship product to reimagine dialysis- Project Nephron. Project Nephron is a wearable, ambulatory hemodialysis device currently under development. Nephria Bio is raising series A financing to bring Project Nephron through development and up to human clinical trials over the next three years.
Along with a successful presentation, Nephria Bio made connections with a wide range of potential investors and identified potential strategic partners for the future. Our CEO Ian Welsford said this after the event: “it was great to interface with a diverse array of thought leaders across the tech investment community and share our vision for Nephria Bio.” Nephria Bio is continuing its fundraising efforts and the development of Project Nephron throughout this year.
Please contact email@example.com or call 603-235-7123 with any questions or comments!
Please note that Project Nephron and any other device mentioned on this site have not been cleared or approved in any jurisdiction, including the FDA, for human use. Statements of possible future product performance are good faith estimates based on preclinical testing. Any information on this website is for informational purposes only and does not constitute medical advice.